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Summary 
We have developed a functional assay to identify processed antigen in subcellular fractions from 
antigen-presenting cells; stimulatory activity in this assay may be caused by either free peptide 
fragments or by complexes of peptide fragments and class II molecules present on organellar 
membrane sheets and vesicles. In addition, we have developed a functional assay to identify proteolytic 
activity in subcellular fractions capable of generating antigenic peptides from intact proteins. 
These techniques permit the direct identification of intracellular sites of antigen processing and 
class II association. Using a murine B cell line stably transfected with a phosphorylcholine (PC)- 
specific membrane-bound immunoglobulin (Ig), we show that PC-conjugated antigens are rapidly 
internalized and efficiently degraded to generate processed antigen within an early low density 
compartment. Proteolytic activity capable of generating antigenic peptide fragments from intact 
proteins is found within low density endosomes and a dense compartment consistent with lysosomes. 
However, neither processed peptide nor peptide-class II complexes are detected in lysosomes from 
antigen-pulsed cells. Furthermore, blocking the intracellular transport of internalized antigen 
from the low density endosome to lysosomes does not inhibit the generation of processed antigen. 
Therefore, antigens internalized in association with membrane Ig on B cells can be efficiently 
processed in low density endosomal compartments without the contribution of proteases present 
within denser organelles. 
~  C, including B cells, macrophages, and dendritic cells, 
internalize exogenous antigens, process them within an 
intracellular compartment(s), and then express on the plasma 
membrane newly generated peptide fragments complexed to 
class II MHC molecules (1-3). Proteases within an acidic en- 
vironment capable of generating antigenic peptide fragments 
are present within both low and high density endosomes, 
as well as within lysosomes; class II molecules are found pre- 
dominantly in the plasma membrane and low density en- 
dosomal compartments (4). In B cells, where antigen is pri- 
marily internalized in association with membrane-bound Ig 
(mlg), 1 a class II-containing endocytic compartment (called 
MIIC or CIIV) with characteristics distinct from endosomes 
and lysosomes has been identified; this may be the major site 
ofpeptide-class II association in these cells (4-6). Conversely, 
macrophages, which efficiently internalize molecules via a 
receptor-independent pinocytic pathway or by phagocytosis, 
1 Abbreviations  used in thispaper: APDE I, alkaline  phosphodiesterase;  BBS, 
CBS, borate- and citrate-buffered  saline, respectively;  CIIV, class II-con- 
taining vesicles; CIM6PR, cation-independent mannose 6-phosphate 
receptor; GAH/x, goat anti-human /x; HRP, horseradish peroxidase; 
LAMP-l, lysosome-associated  membrane  protein-l; mIg, membrane-bound 
Ig; MIIC, MHC class II-positive  compartment;  PC, phosphorylcholine; 
RGG, rabbit gamma  globulin; TfR, transferrin  receptor; t-OVA, tryptic 
fragments of OVA. 
appear to use lysosomes or lysosome-like organdies for pro- 
cessing before class II association (7, 8). Moreover, reduction 
of disulfide-linked markers, presumably important in the sub- 
sequent proteolytic degradation of some antigens, also occurs 
predominantly within lysosomes (9). 
A significant limitation in many of the studies done to iden- 
tify the intracdlular site(s)  of antigen processing and class 
II association is the reliance on indirect approaches for studying 
processing. In this article, we describe a series of assays that 
directly identify, within subcellular fractions of B cells, either 
functional peptide--class II complexes capable of stimulating 
T ceils, free antigenic peptide, or proteolytic activity capable 
of generating antigenic peptides. We also present evidence 
that although proteolytic enzymes are present in low density 
endosomes and in denser lysosomal compartments, the gener- 
ation of functional peptide-class II complexes does not re- 
quire a contribution of the denser organdies. Therefore, an- 
tigen internalized bound to mlg may be exclusively processed 
within low density endosomes. 
Materials and Methods 
Cell Lines.  A20 murine B lymphoma cells (3,2a  +  , ~+, H-2 d) 
were transfected with phosphorylcholine (PC)-specific human It 
heavy chain constructs, cloned, and maintained as described previ- 
ously; surface expression of the transfected mlgM averaged 1-2  x 
l0  s molecules per cell (10). The I-Ad-expressing M12.4.1 cell line 
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Laurie Glimcher (Harvard School of Public Health, Boston, MA). 
The T cell hybridomas used were DO.11, specific for OVA peptide 
fragment  OVA323-339 in  the  context  of I-A  d (12),  and  2R.50, 
specific for processed F(ab')~ fragments of rabbit Ig (RGG; specific 
peptide unknown),  in the context of I-A  d (13). 
Antibodies.  F(ab')2 fragments  of KGG  (F(ab')2-R.GG)  were 
from Cappel (Organon Teknika, R.ockville, MD), and intact R.GG 
and goat gamma globulin were from Sigma Chemical Co. (St. Louis, 
MO).  FITC-,  PE-, biotin-,  and horseradish peroxidase (HRP)- 
conjugated  antibodies  were  from Southern Biotechnology As- 
sociates, Inc. (Birmingham, AL); reagents containing azide were 
dialyzed against PBS before use. TIB 219 (R.17 217.1.3), a rat mono- 
clonal antibody against mouse transferrin receptor (TfR), was from 
the hybridoma supernatant (American Type Culture Collection, 
Kockville, MD). Antibody against lysosome-associated membrane 
glycoprotein-1 (LAMP-l) was from 1D4B hybridoma supernatants 
(generated by T. August, distributed through the Developmental 
Studies  Hybridoma Bank, Iowa, City, IA, and maintained on a 
contract from the National Institute of Child Health and Human 
Development  [NO1-HD-6-2915]).  mAbs  to  I-A  d  (MKD6), 
I-Ab'd'q/I-Ed'k (M5/114), I-A  b,f,Lp,q  ........  (Y-3P), and PC (TEPC 15) 
were from hybridoma supernatants of the respective clones. Poly- 
clonal rabbit antisera against bovine and rat cation-independent  man- 
nose 6-phosphate receptor (CIM6PR.;  insulinlike  growth factor-II 
receptor; [14]) were generous gifts from Drs. G. Gary Sahagian 
(Tufts University, Boston, MA) and Michael Czech (University 
of Massachusetts  Medical Center, Worcester, MA), respectively. 
Pret~arationofPC-conjugatedProteins.  OVA (Sigma Chemical Co.) 
and F(ab')2-R.GG were PC-haptenated as described previously (10). 
Diazo-PC was synthesized by dissolving 1.1 equivalents of NaNO~ 
into a solution ofp-aminophenylphosphorylcholine  (Sigma Chemical 
Co.) in 0.1 N HC1 maintained at pH 1-2 and 15-18~  for "~15 min. 
Internalization  of Bound Ligand.  Cells  (typically >12  x  10  s) 
were incubated in 1-2 ml of culture medium containing 50-100 
/~g/ml of specific antibody (PE-conjugated goat  anti-human  /~ 
[GAH/x])  or antigen (PC-OVA)  for 30 rain on ice, followed by 
a wash in culture medium. Treated cells were split into equal volumes 
and either maintained on ice ("time 0" control) or incubated at 
37~  for varying periods of time, Incubations were terminated with 
a 15-fold excess of ice-cold medium followed by centrifugation (10 
min,  300 g) at 4~ 
Experiments to disrupt intracellular trafficking were performed 
by pretreating cells with antigen or antibody at 4~  followed by 
washing and incubation for 30 min at 18~ 
Subcellular Fractionation.  Cells were suspended in 7 ml homogeni- 
zation buffer (0.3 M sucrose, 0.01 M Hepes, 10 #g/ml leupeptin, 
40/~g/ml pepstatin A, and 200/xM PMSF [Sigma Chemical Co.], 
pH 7.2) and ruptured by nitrogen cavitation after equilibration at 
450 psi for 5 min at 4~  yielding 85-90% rupture. After cen- 
trifugation at 850 g for 10 min to remove intact cells and nuclei, 
I ml of supernatant material was removed to quantify total activity 
applied; the remaining 6 ml was centrifuged over 24 ml of 25.4% 
Percoll (Sigma Chemical Co.) with 0.3 M sucrose, 0.01 M Hepes, 
and the same protease inhibitors as above (pH 7.2, 8 =  1.129 g/ml) 
for 1 h 45 min at 20,000 rpm in a centrifuge (model J2-21 M/E, 
rotor model JA-20; Beckman Instruments,  Inc., Fullerton, CA; 
average force •30,000  g). Fractions (0.8 ml) were recovered from 
each gradient by gravity siphon; the approximate density of frac- 
tions was assessed by adding density marker beads (Pharmacia Inc., 
Piscataway,  NJ) to parallel  gradients.  To evaluate proteolytic ac- 
tivity in subcellular  fractions, homogenization buffer and Percoll 
were prepared without protease inhibitors. In some experiments, 
fractions comprising the plasma membrane and low-density endo- 
somes were pooled and centrifuged for 45 rain at 20,000 rpm over 
11% Percoll gradients; the entire gradient was then collected in 
30 1-ml fractions. 
The distribution of intracellular organelles  was defined using 
enzymatic assays for plasma membrane (alkaline phosphodiesterase 
I [APDE I] [15]), Golgi apparatus (UDP-galactose  galactosyl trans- 
ferase [16]), and lysosomes (3-hexosaminidase  [17]), all adapted to 
microtiter  plates.  The  distribution  of PE  was  determined by 
solubilizing 100-200 #1 of fractions in 2 ml of PBS/0.01% Triton-X 
100 and reading fluorescence at 488 nm excitation/580 nm emis- 
sion; background fluorescence due to Percoll was determined by 
measuring parallel  "blank" Percoll gradients. 
Measurement of  Antigenic Activity in Subcellular Fractions by ELISA. 
The distributions of mIgM, PC, TfR, CIM6PR., LAMP-l, and 
class II were determined by ELISA.  Till is distributed between 
plasma membrane and early endosome (18). CIM6PR is used as 
a marker for late endosomes/prelysosomes (19, 20), although it is 
also found in most organdies of the biosynthetic and endocytic 
pathways,  with  distributions  that  vary among  cell  types  (21). 
LAMP-1  is a heavily glycosylated protein originally described  in 
lysosomal membranes (22), but it is also present in the late endo- 
some/prelysosome and early endosomal compartments (23). 
ELISA was performed on 25-50 #1 of Percoll fractions,  which 
had been dried onto flexible microtiter plates (Micro Test III; Falcon 
Plastics, Cockeysville, MD). After drying, the wells were blocked 
with 200/~1 of 2% BSA in borate-buffered saline (BBS) for 1-2 h 
at 37~  washed with PBS/0.01% Triton-X 100, and dried. TfR, 
LAMP-l, class II, and CIM6PR antigenic distributions were evalu- 
ated by incubating plates with 100/~1 of 1:20-1:100 dilutions of 
the relevant hybridoma supernatants or polyclonal antisera in 2% 
BSA/BBS for 1-2 h at 37~  washing with PBS/Triton-X 100, 
and probing with 100/~1 of appropriate HRP-conjugated antisera 
at  1:1,000 dilutions in 2% BSA/BBS for 1-2 h at 37~  Trans- 
fected human mlgM was probed with 100 #1 of 1:1,000 dilutions 
of isotype- and species-specific HRP-conjugated antisera  in 2% 
BSA/BBS. PC was localized by using antibody from the PC-spedfic 
murine IgA myeloma, TEPC 15, followed by HRP-goat anti-mouse 
IgA.  After  1-2  h  at  37~  the ELISA  plates  were washed  in 
PBS/Triton X-100, and captured HRP activity was assayed  by adding 
100 #I of citrate buffer (0.1 M sodium citrate, 0.1% Triton-X 100, 
pH 4.2) plus  50/~1  of 1 mM substrate/0.03%  H20~ in citrate 
buffer (substrate =  2,2'-azino-di[3-ethylbenzthiazoline-6-sulfonic 
acid] diammonium salt [Sigma Chemical Co.]) for 15-45 min at 
room temperature. Color was quantitated at 414 nm on an EIA 
reader (model 2550; Bio-Rad Laboratories,  R.ichmond,  CA) using 
standard dilution curves of HRP-conjugated antibodies or human 
IgM myeloma protein (Cappel Laboratories) dried onto the micro- 
titer plates. Compared with starting material applied to the Percoll 
gradients, recoveries of enzymatic or antigenic activities were within 
15% for all time points in a given experiment, and varied from 
60 to 130% of total applied  activities. 
In control experiments, detection of mlg by the ELISA tech- 
nique was sensitive to '~0.01 ng/ml. For control cells not previ- 
ously treated with anti-Ig, detection of mlg was virtually quan- 
titative (10). After binding of monoclonal or polyclonal anti-IgM 
at 4~  up to 50% of the surface # remained detectable using the 
ELISA technique; for up to 30 min after internalization, the total 
recovery of antigenic activity from the subcellular  fractions was 
comparable.  Thus, the absolute levels of detectable mlg remained 
relatively constant within a given experiment and without variable 
losses caused by proteolytic degradation or competition from the 
internalizing antibody. 
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tinely performed in all experiments and for every time point to 
standardize for slight gradient-to-gradient variations. The distri- 
butions of the other markers were not routinely assayed; however, 
when examined, their distributions did not vary significantly as 
a function of mlg-mediated antigen internalization or time of in- 
cubation. 
Antigen Processing and Presentation.  To determine the kinetics 
of the generation of processed antigen, A20 cells were washed and 
incubated at 106/ml with 30/~g/ml PC-OVA or 300/xg/ml OVA 
in culture medium for various lengths of time before washing and 
fixation in 1% paraformaldehyde/PBS for 30 min at room temper- 
ature. After washing,  105 of these cells were incubated with 105 
DO.11  cells in 0.2  ml of culture medium in triplicate for 24 h. 
Generation of IL-2 in the cultures was assessed by an HT-2 assay 
as described previously (10) using [3H]dT incorporation (New En- 
gland Nuclear, Boston, MA) and/or XTT (Sigma Chemical Co.) 
colorimetric assay (24) to quantitate IL-2 levels. IL-2 standard curves 
were generated using IL-2 generously provided by Dr.  Andrew 
Lichtman (Harvard Medical School,  Boston,  MA) from the IL- 
2-transfected X63 cell line (25).  Results are expressed as the av- 
erage of triplicate cultures;  standard deviations were consistently 
<15%. To remove processed peptide-class II complexes from the 
cell surface, cells were incubated 1 h on ice with 10 mg/ml pronase 
(Calbiochem Corp., LaJolla, CA), and washed in 5% BSA/RPMI 
before further use. 
To assay processed antigen in subcellular fractions, 2-4  x  l0 s 
transfected A20 cells were washed and incubated for 15-30 min 
on  ice  at  10S/ml  in  RPMI  with  100  /~g/ml  PC-OVA.  After 
washing, the cells were incubated for 15 min at 37~  in 1-2 ml 
culture medium,  washed in ice-cold culture medium,  and then 
sterilely  homogenized and fractionated as described above.  Frac- 
tions were sterilely sonicated (model 250; Branson Ultrasonics Corp., 
Danbury, CT) with a microtip at power level 1.5 for 10 s; 0.25 
ml of each fraction was incubated for 4 h  at 37~  with 0.5  ml 
of paraformaldehyde-fixed (1%, 30 min at room temperature) and 
washed APC at 106 cells/ml in PBS at pH 7.2.  In most experi- 
ments, the APC used were M12.4.1  (class II+); in some experi- 
ments, the class II- cell  line M12.C.3  was used.  After washing 
with culture medium, 105 of these APC were incubated with 10  s 
DO.11 in triplicate in a final volume of 0.2 ml culture medium; 
in experiments involving the presentation of RGG, 2R..50 T cells 
were substituted for the DO.11. Supernatant IL-2 activity was as- 
sessed after 24 h as described above. Control incubations included 
0.5 ml of fixed APC with 0.25 ml of homogenization buffer or 
Percoll medium plus 100-200/~1  of (a) culture medium; (b) OVA 
or PC-OVA at 4 mg/ml; and (c) tryptic fragments of OVA (t-OVA; 
[26])  at 4 mg/ml. 
To assay the distribution  of proteolytic antigen-processing ac- 
tivity in untreated cells, nitrogen cavitation and Percoll fraction- 
ation were performed in the absence of protease inhibitors. Fixed 
APC were incubated with subcellular  fractions at pH 5.0 in citrate- 
buffered saline (CBS; 0.015 M citrate,  0.01 M Na2HPO4, pH 5.0). 
This pH value was used because endosomal and lysosomal proteases 
have acidic pH optima, pH 5 approximates the normal physiologic 
pH of these organelles (27),  and the formation of antigen--class 
II complexes is accelerated  at lower pH (28).  However, Percoll 
precipitated at pH 5; therefore, subcellular  fractions were first soni- 
cared, precipitated with an equal volume of CBS, and centrifuged 
for 10 min at 850 g. One-half milliliter of the supernatants was 
then incubated with 0.5 ml of fixed APC at 106 cells/ml in the 
presence of 100/xl of 4 mg/ml OVA for h at 37~  Control incuba- 
tions with homogenization buffer or Percoll in place of subcellular 
fractions were performed as described above.  APC were washed 
and incubated with DO.11 cells as described above. In some experi- 
ments, pepstatin A was added to the subceUular fraction-APC-OVA 
mixture at a final concentration  of 36/xg/ml. 
To  examine  whether  subcellular  fractions  could  be  directly 
stimulatory for DO.11, 25/~1 of sonicated fractions was plated in 
triplicate and 75/~1  of water was added;  control triplicate wells 
with culture medium, OVA, and t-OVA were prepared similarly. 
These were allowed to dry at 37~  10  s DO.11  per well in 0.2 
ml were then added and IL-2 production after 24 h was assessed 
as described above. The ability of MKD6 (anti-I-A  a) to block an- 
tigen presentation was assessed by adding 100/~1 of hybridoma su- 
pernatants to the final APC  +  DO.11 cultures (final vol  =  0.2 
ml). Parallel control experiments used isotype-matched antibodies 
against an irrelevant class II molecule (Y-3P). 
Results 
Subcellular Distribution of  Internalized Antigen and mI~  Func- 
tional assays showed that processed antigen capable of stimu- 
lating OVA-specific T  ceils was detectable on the surface of 
mlgM-transfected A20 cells within 15 min of incubation with 
PC-OVA (10,  29,  Fig.  1).  This is consistent with the rapid 
rates of internalization of mlg described by ourselves and others 
(29-32). In comparison, nonhaptenated OVA was much more 
slowly processed to stimulatory antigenic  fragments,  with 
50-100-fold less stimulatory activity, even after a 2-h antigen 
pulse (Fig.  1). The difference in the efficiency of processing 
of PC-OVA versus OVA is presumably caused by different 
efficacy of antigen uptake when bound to mlg versus fluid- 
phase pinocytosis,  as well as in intracellular  targeting.  The 
fact that antigen bound and internalized in association with 
mlg is rapidly processed to antigenic fragments suggests that 
processing  occurs in  an early endocytic  compartment. 
Based on this functional assay, we predicted that by 15 min 
of internalization, a significant proportion of antigen and mlg 
would be present within a relevant processing compartment. 
100 
10- 
continuous antigen ~# 
T  PC-OVA 
OVA 
incubation time (min) 
Figure  1.  Kinetics  of antigen processing and presentation. PC-specific 
human IgM-transfected  A20 cells were incubated at 105/ml with 30/~g/ml 
PC-OVA (A) or 300/~g/ml OVA (￿9  for various lengths of time at 37~ 
followed by washing and fixation in 1% paraformaldehyde. 105 cells were 
incubated in triplicate culture wells with 105 DO.11 cells; after 24 h, IL-2 
production in the culture supernatants was measured by HT2 assay. The 
results are expressed as the average of triplicate cultures; standard devia- 
tions are <15%. The data points indicated as "continuous antigen" repre- 
sent cultures where antigen, transfected  A20 cells, and DO.11 were present 
together continuously in culture for 24 h. 
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In the next set of experiments, we used subcellular fraction- 
ation to determine the intracellular location of mlg and an- 
tigen.  Transfected A20 cells were incubated with PC-OVA 
on ice, washed,  and either ruptured immediately (time 0) 
or incubated for 15 rain at 37~  before rupture. Subcellular 
fractions were then assayed  for organellar marker profiles and 
for transfected human g  and PC. 
Fig. 2 A shows a characteristic distribution of enzymatic 
activity from fractionated A20 cells. Plasma membranes were 
identified by the low density peak of APDE I activity (/~ = 
1.04 g/ml) and lysosomes  by the high density peak of B-hexo- 
minidase activity (6 =  1.08 g/ml). The distribution of anti- 
genic activities from the same fractions is shown in Fig. 2 
B; the lower density peak of TfR activity was interpreted 
as plasma membrane associated, whereas the slightly denser 
second peak was consistent with early endosomes. The dis- 
tribution of CIM6PR showed a major peak of activity corre- 
sponding  to plasma membrane, with a smaller shoulder of 
activity interpreted  as early endosomal; the densest peak of 
activity (fraction 3) was attributable  to CIM6PR in associa- 
tion with elements of the Golgi complex. The peak of ac- 
tivity at  fractions  6-8 was attributed to late endosomes/ 
prelysosomes  based on its intermediate density (6 =  1.07 g/ml) 
and increased CIM6PR activity  (33). The distribution of 
LAMP-1 showed a predominant dense peak of antigenic ac- 
tivity corresponding to lysosomes, with a lesser peak coinci- 
dent with early endosomes. 
The initial distributions  of both mlgM and ligand after 
binding PC-OVA on ice (Fig. 2 C) were largely consistent 
with plasma membrane, although the mlgM peak frequently 
straddled the APDE I and TfR distributions.  After inter- 
nalizing  PC-OVA for 15 min at 37~  the bulk of mlgM 
was present at a density consistent with migration into a low 
density endosomal compartment (Fig. 2 D); mlgM remained 
at this density up to 30 min (not shown).  Although mlg 
that has been endocytosed without bound antigen, or after 
binding monovalent antigen or monoclonal anti-/~ antibodies, 
can recycle back to the plasma membrane (30, 34, 35), we 
have been unable to document such recycling  with cross-linked 
Figure 2.  Subcellular fractionation of transfected A20 cells; distribu- 
tion of organeUar markers,  mlgM, and internalized antigen. Calls were 
incubated with 50 #g/ml PC-OVA at 4~  followed by washing, inter- 
nalization for 15 rain at 37~  and stopping with a large excess of ice-cold 
medium. Cells were ruptured by nitrogen cavitation and fractionated on 
self-forming Percoll gradients as described in Materials and Methods. Fraction 
I represents the highest density; fraction 22 is the lowest density. Charac- 
teristic enzymatic marker activities are shown in A  (--,  plasma mem- 
brane [APDI]; ~a, lysosomes [/J-hexosaminidase]; "-% Golgi complex 
[UDP-galactose  galactosyl transferase]); characteristic  antigenic profiles, 
as determined by ELISA, are shown in B (--,  transferrin  receptor; ~m, 
CIM6PR; ~',  lysosome-associated membrane protein-I). The antigenic 
distribution of PC and transfected  human/z are shown in C  at time 0, 
before internalization, and in D after 15 min at 37~  (~,  transfected 
human/~ [ELISA]; ~,  phosphorylcholine [ELISA]). Distributions are 
expressed as a fraction of total activity recovered from the entire gradient; 
data points are from single determinations from each fraction. 
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Figure  3.  Distribution of processed antigen in subcellular  fractions. 
Transfected A20 cells were incubated  with 100/~g/ml PC-OVA or PC- 
F(ab')z-RGG at 4~  followed by washing,  internalization  for 15 rain at 
37~  and stopping  with an excess of ice-cold medium. The cells were 
ruptured and fractionated as described in Materials and Methods.  (.4) Dis- 
tributions ofAPDE I (~),/3-hexosaminidase ~),  and TfR (m). (B) 
Fractions from cells treated with PC-OVA (---) were sonicated and in- 
cubated with paraformaldehyde-fixed M12.4.1 (class II*) APC for 4 h at 
37~  The APC were  then washed  and  10  s were  incubated  with  10  s 
DO.11 in triplicate wells for 24 h. II.-2 levels in the supernatant  were de- 
termined by HT2 assay, and they are expressed as the average of the tripli- 
cate cultures (SD g20%). Ib2 values for control incubations of fixed APC 
are as follows: control (medium only), 0 U/ml; 4 mg/ml OVA, 0.4 U/ml; 
4 mg/ml t-OVA,  12 U/m1. (C) Fractions  from cells treated  in another 
experiment with PC-OVA or PC-F (ab')2-RGG were sonicated and in- 
cubated for 4 h at 37~  with fixed and washed M12.4.1. The APC were 
then washed  and 10  s were incubated  with 10  s DO.11  or 2R.50 as indi- 
cated in triplicate wells for 24 h, followed by HT2 assay for Ib2 produc- 
tion. IL-2  values for control incubations of fixed APC with DO.11 or 2R.50 
are as follows: control (medium  only), 0 U/ml; 4 mg/ml OVA, 0 U/ml; 
4 mg/ml ILGG: 0 U/ml; IL-2 values for control incubations of fixed APC 
with 4 mg/ml t-OVA and DO.11,  29.7 U/ml, or 2R..50, 0 U/ml. m 
mlg at times up to 4 h. In contrast to the mlgM, the inter- 
nalized hapten PC was found predominantly in denser frac- 
tions at 15 min, including a peak of activity corresponding 
to lysosomes. It is likely that internalized PC-OVA was released 
by a shift in pH and/or digested by proteases into the en- 
dosomal lumen and was then passively carried along the normal 
endocytic pathway (36,  37), accumulating in the lysosome. 
These results demonstrate that by the time dass II-peptide 
complexes can be detected on the cell surface, ligand inter- 
nalized on mlg is found within both low and high-density 
intracellular compartments, including lysosomes. 
Functional Processed  Antigen in Subcellular Fractions.  In the 
next series of experiments, we used a functional T cell stim- 
ulation assay to identify the intracellular compartment where 
antigen is processed. Transfected A20 cells were pulsed with 
PC-OVA or PC-F(ab')2  RGG,  ruptured,  and fractionated. 
Fractions were sonicated and incubated with a fixed class II + 
B cell line (M12.4.1);  after washing unbound material, the 
fixed B cells were incubated with specific T cell hybridomas 
(DO.11 for OVA or 2R.50 for RGG),  and IL-2 was mea- 
sured in 24-h supernatants. 
As shown in two representative experiments illustrated in 
Fig.  3,  B  and  C,  processed  OVA  and  RGG  capable  of 
stimulating specific T cells were detected mainly in low den- 
sity endosomal compartments. The shoulder of antigenic ac- 
tivity in lower density fractions (Fig.  3 B, fractions 17-19) 
was not consistently seen, and may reflect material that has 
already returned to the plasma membrane during the 15-min 
incubation. The response in this assay was antigen specific, 
since transfected A20 cells incubated with PC-F(ab')2-RGG 
did not stimulate the OVA-specific T cell hybridoma, DO.11 
(Fig.  3 C). Moreover, the recognition of processed antigen 
was class II restricted, since it was completely blocked by 
adding  an  anti-I-A  a antibody (MKD6)  to  the culture of 
fixed APC and T cells (Fig. 4 B); an irrelevant isotype-matched 
antibody, Y-3P,  had no effect (not shown). In these assays, 
maximal responses of DO.11 cells were typically 1-15 U/ml, 
with responses to fixed APC plus t-OVA fragments being 
10-125  U/ml.  Intact OVA was not presented by the fixed 
APC, indicating that the assay detects processed antigenic 
fragments. It is noteworthy that in A20 cells (and other B 
cell lines), class II is present largely within plasma membrane 
fractions, with only a small fraction corresponding to the 
low density endosomal compartment (4, Fig. 4 A). This is 
in  agreement with  previously published  work using  im- 
munogold-electron microscopy (5, 38-40). 
To determine if the processed antigen detected by this assay 
consisted of free or class II-associated peptides, transfected 
A20 cells were pulsed with PC-OVA, ruptured, and subcel- 
lular fractions were incubated either with fixed class II + or 
class II-  APC.  The APC were then washed and cultured 
PC-OVA-treated ceUs/DO.11; am, PC-F(ab'h-RGC,-treated  cells/DO.11; 
=='=, PC-F(ab')2-RGG-treated  cells/2R.50. 
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Recognition of intraceUularly generated  processed antigen  Figure  4. 
is class II restricted.  Transfected A20 cells were incubated with 100/zg/ml 
PC-OVA and fractionated as described in Fig. 3. (.4) Distributions  of APDE 
I, B-hexosaminidase, TfR, and class II. The distribution of class II anti- 
genic activity was determined by ELISA using M5/114  antibody.  ~, 
plasma membrane;  m,  lysosomes; ￿9  ~ o, transferrin  receptor; m,  MHC 
class II. (B) Processed antigenic  activity was determined  as described in 
Fig. 3; blocking anti-I-Aa antibody MKD6 was added as  100 pl of hy- 
bridoma supernatant  to the final APC/DO.11 culture (total  volume  = 
0.2 ml).  IL-2 values for control incubations  of fixed APC are as follows: 
control (medium only) with and without MKD6, 0 U/ml; 4 mg/ml OVA 
with and  without MKD6, 0 U/ml; 4 mg/ml t-OVA without MKD6, 
110  U/ml; 4  mg/ml t-OVA with MKD6,  43.3  U/ml. 
with DO.11  cells.  T  cell  stimulatory activity was seen even 
when the subcellular fractions from antigen-pulsed cells were 
incubated with fixed class II-  APC (Fig. 5 B) or when dried 
onto culture wells (Fig. 5 C). In three experiments,  incuba- 
tion  of fractions  with  fixed class  II-  cells  resulted  in peak 
stimulations that were 75  +  30% of those obtained by incu- 
bation with class II + APC.  Therefore,  the assay detects pre- 
dominantly processed peptide-class  II complexes.  However, 
the possibility  that a smaller fraction of the stimulator), ac- 
tivity results from free processed peptides cannot be excluded. 
Indeed, in A20 cells expressing tyrosine transmembrane mu- 
tants of the mlgM,  antigen is bound and internalized  to an 
intracellular  compartment(s)  where  processing  occurs,  but 
no class  II association  takes  place (29);  subcellular fractions 
from  these  antigen-pulsed  mutant  A20  cells  can  stimulate 
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Figure  5.  Characterization  of the stimulatory  activity from subcellular 
fractions.  Transfected A20 cells were incubated  with PC-OVA and frac- 
donated as described in Fig. 3.  C  A) Distributions of APDE I, /3-hexo- 
saminidase, TfR, and class II. m,  plasma membrane;  m,  lysosomes; 
￿9  ￿9  ~  transferrin  receptor;  m,  MHC class II. (B) Processed antigenic ac- 
tivity was determined as described in Fig. 3, and by incubating  subcellular 
fractions  with either fixed MHC II § ~,  M12.4.1) or fixed MHC II- 
(m,  M12.C.3) cells, and culturing with DO.11.  1I.-2 values for control 
incubations  are as follows: control (medium  only)  with either APC, 0 
U/ml; 4 mg/ml OVA with either APC, 0 U/ml; 4 mg/ml t-OVA with 
M12.4.1  (MHC  II + APC),  8  U/ml; 4  mg/ml t-OVA  with  M12.C.3 
(MHC II- APC), 0.01 U/ml. (C) Fractions were either incubated with 
fixed M12.4.1 APC as described in Fig. 3 ~)  or they were sterilely dried 
onto microtiter wells (~)  in triplicate  and  washed  before adding  105 
DO.11  in a final volume of 0.2  ml. IL-2 values for control incubations 
of fixed APC are as follows: control (medium  only),  0 U/ml; 4 mg/ml 
OVA, 0 U/ml; 4 mg/ml t-OVA, 67.3 U/ml. IL-2 values for controls dried 
onto microtiter plates are as follows: control (medium  only),  0 U/ml; 4 
mg/ml OVA, 0.4 U/ml; 4 mg/ml t-OVA, 0  U/ml. T  cells when incubated with class II + APC, but not when 
incubated with class II-  APC. Thus, by using class II + or 
class II-  APC,  free processed peptide and peptide-class  II 
complexes in subceUular fractions can be distinguished (29). 
That the results with wild-type transfected mlgM are similar 
whether subcellular fractions are incubated in the presence 
of either  class  II +  or  class  II-  fixed  APC  indicates  that 
processed peptide fragments are rapidly and efficiently com- 
plexed to class II molecules in the low density compartment. 
It is also worth  emphasizing  that  this  assay detected pep- 
tide-class II complexes that are generated after mlg-mediated 
antigen internalization,  but it fails to detect such complexes 
after unhaptenated OVA is internalized by fluid-phase pinocy- 
tosis (not shown). This is presumably related to the inefficient 
concentration of processed peptides in any one intracellular 
site after uptake by pinocytosis. 
Percoll fractionation  does not yield a large separation of 
plasma membrane and low density endosomes; therefore, it 
was important to demonstrate that the processed peptide-class 
II complexes we detected were in fact intracellular,  and not 
simply complexes that had already recycled to the plasma mem- 
brane. We verified this in two ways. First, fractions containing 
plasma membrane and low density endosomes from a stan- 
dard 25.4% gradient of antigen-pulsed A20 cells were pooled 
and reseparated over a second 11% Percoll gradient (Fig.  6). 
In this manner,  early endosomes, as marked by the denser 
TfR peak, are cleanly separated from the low density plasma 
membrane  marked by APDE I  (Fig.  6 B).  Fractions  from 
this same gradient,  assayed for processed peptide, showed a 
broad prominent peak at an intermediate density (8 =  1.044 
g/ml) between the plasma membrane and early endosomes, 
and clearly distinct  from both  (Fig.  6  C).  Interestingly,  a 
smaller amount of activity was detected coincident with the 
early endosomes, suggesting that processed peptides may be 
present within that organelle as well. Finally, the intermediate 
compartment containing processed peptide has relatively little 
class II (Fig.  6 B); this may result from the relative insensi- 
tivity of the solid-phase ELISA assay used to detect class II 
molecules,  but  is  in  general  agreement  with  others  who 
showed that  the majority  of class  II  is plasma membrane 
associated (4,  41). 
The  second approach  we used to  demonstrate  that  the 
stimulatory peptide-class II complexes were not on the plasma 
membrane involved removing surface complexes by proteo- 
lytic digestion. As shown in Fig. 7 A, a 1-h incubation with 
pronase reduced the ability of antigen-pulsed and subsequently 
fixed A20 cells to  stimulate DO.11  cells by >60%.  Fig.  7 
B shows that subcellular fractions from antigen-pulsed A20 
cells yielded comparable amounts of processed peptide whether 
or not the cells were treated with pronase before fraction- 
ation. Therefore, the complexes detected are within intracel- 
lular  organelles. 
Proteolytic Activity in Subcellular Fractions.  A possible reason 
that we did not detect processed antigen in denser organelles 
may be that these compartments lack the enzymes required 
to generate stimulatory peptide fragments.  To examine the 
subcellular distribution of proteolytic activity, sonicated frac- 
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Figure 6.  Separation  of processed  antigenic activity  from plasma mem- 
brane and early endosomes. Transfected A20 cells were incubated with 
PC-OVA and initially fractionated as described  in Fig. 3. (.4) Character- 
istic activities  in the 25.4% gradient. Fractions corresponding to the plasma 
membrane peak and indicated low density endosomal fractions were  com- 
bined and refractionated over an 11% Percoll gradient as described in 
Materials and Methods. (B) Characteristic activities in the 11% gradient. 
(C) Processed  antigenic activity in the 11% gradient was determined as 
described in Fig. 3. 
tions from A20 cells not exposed to antigen or protease in- 
hibitors were incubated with OVA at pH 5 in the presence 
of fixed M12.4.1 cells. Extracellular (ex vivo) processing and 
class II association were allowed to occur, followed by washing 
and incubation of the fixed APC with DO.11 cells; 24-h su- 
pernatants  were then assayed for IL-2. As shown in Fig. 8 
C, both low density endosomes and denser lysosomes were 
capable of generating antigenic peptide fragments that could 
associate with class  II molecules. A  parallel  gradient  from 
antigen-pulsed  A20 cells again showed that processed pep- 
tide-class II complexes were only seen in the low density com- 
partment  (Fig.  8 B). On average,  proteolytic activity in en- 
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Figure 7.  Processed  antigenic activity is intracellular because it is not 
released from intact cells by proteolysis. (A) Transfected A20 cells were 
either kept on ice without antigen (control~no  antigen) or pulsed with 100 
~g/ml PC-OVA  and incubated  60 min at 37~  Antigen-pulsed  cells were 
then washed  and incubated  on ice for 1 h with or without 10 mg/ml pronase; 
the control cells received 10 mg/ml pronase for 1 h on ice. All cells were 
then washed, fixed, and used as APC in culture with DO.11 as described 
in Fig. 1; 24-h supernatants were assayed for IL-2. (B) Transfected A20 
cells were pulsed  with 100 #g/ml PC-OVA and incubated  30 rain at 37~ 
the cells were  then washed  and treated with or without 10 mg/ml pronase 
as described  in A. After washing, cells were fractionated and assayed  for 
processed antigenic activity as described in Fig. 3. 
dosomes accounted for 37.5% of the total activity across the 
gradient,  while lysosomes accounted for 62.5%  (n  =  15). 
Although smaller shoulders of activity in intermediate den- 
sities were occasionally seen, no distinct antigen-processing 
activity attributable to higher density endosomes was con- 
sistently identified. Control experiments with medium con- 
taining 10% calf serum or with RGG in place of OVA showed 
no activity. Pepstatin A, a cathespin D  inhibitor previously 
shown to abrogate OVA processing (42), inhibited both early 
endosome and lysosome proteolytic activities  to  the  same 
extent (65%  inhibition  _+  30%;  n  =  4).  Thus,  processed 
peptide-class II complexes are generated only in low density 
endosomes in intact cells, although both endosomes and lyso- 
somes contain the enzymes necessary for antigen processing. 
Internalized  Antigen  Does  Not Require  Processing in Lyso- 
somes.  From Fig. 2 D,  it is apparent  that  after  15 min of 
incubation, internalized antigen is found in both endosomal 
and lysosomal compartments. Moreover, both compartments 
have enzymes capable of generating  stimulatory fragments 
from intact  OVA  (Fig.  8  C).  Thus,  it  is conceivable that 
processed antigen-class II complexes detected within the low 
density endosome derive from antigen initially catabolized 
in lysosomes and then recycled to a lower density compart- 
ment,  where it  associates  with class  II molecules. 
Since the trafficking of material from low density endo- 
somes  to  late  endosomes  and  lysosomes is  dependent  on 
microtubules and therefore may be inhibited by low temper- 
ature incubation (36, 43, 44), we asked if incubation at 18~ 
would inhibit the intracellular generation of processed pep- 
tide.  To demonstrate that  this treatment  blocks trafficking 
of an internalized  ligand,  we used PE-GAH# since the PE 
fluorescence signal is readily detected and quantifiable. 
A20 cells were incubated with PE-GAH/z on ice and then 
shifted to either 18 or 37~  for a subsequent 30-min incuba- 
tion, followed by subcellular fractionation  and assay of PE 
fluorescence. In parallel,  A20 cells were incubated with PC- 
OVA and allowed to internalize  at  18 or 37~  for 30 min 
before fractionation and assay of fractions for processed pep- 
tide. As shown in Fig. 9 B, incubation at 18~  blocked the 
accumulation of PE in denser organelles;  however, the gener- 
ation of processed peptide was not affected (Fig.  9 C). This 
result is discrepant with data demonstrating that incubation 
at 18~  interferes with the presentation of hen egg lysozyme 
taken up by nonspecific pinocytosis in macrophages  and a 
B cell clone TA3 (45). However, this may be due to a blockade 
in surface expression of newly generated peptide-dass II com- 
plexes, which possible complication is avoided by use of the 
subcellular fractionation assay. Notably, Roederer et al. (46) 
have found that catabolism of a cathepsin B substrate inter- 
nalized by fluid-phase pinocytosis was not blocked by incu- 
bation at 13-21~  although they did not examine the ability 
of this internalized  antigen to be processed. Additional ex- 
periments using microtubule inhibitors to interfere with ac- 
cumulation of endocytosed ligand in denser organelles showed 
that concentrations of colchicine or nocodazole (up to 100 
/~M) sufficient to disrupt microtubules in nontransfected A20 
cells (as evaluated by fluorescence microscopy [47]) did not 
affect the accumulation of PE in dense organelles (results not 
shown). Nevertheless, the incubation at 18~  demonstrates 
that,  at least for the case of OVA, proteolytic degradation 
within  the low density endosome is sufficient  to generate 
antigenic fragments without any contribution from proteo- 
lytic activity in denser organelles. 
Discussion 
We have developed a set of sensitive and interrelated bioas- 
says that can examine the various steps in the  sequence of 
antigen processing and class II-associated presentation.  By 
using subcellular fractions from antigen-pulsed  APC incubated 
with class II + cells, processed peptide in various intraceUular 
sites can be assayed; by incubating fractions with class II- 
cells or in plastic wells, processed antigen-class II complexes 
may be identified. In addition, by using subcellular fractions 
from untreated  APC in the presence of intact  antigen  and 
fixed class  II + cells,  the proteolytic processing capacity of 
various compartments can be directly assessed. These assays 
have an advantage over others that  rely exclusively on the 
conformational change of class II molecules to assess intra- 
cellular formation  of peptide-class  II complexes (4,  6,  48) 
since class II conformational change only indirectly infers the 
intracellular  site of antigen  processing. 
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Figure 8.  Subcdlular distribution of proteolytic activity capable of gener- 
ating stimulatory antigenic fragments.  Transfected A20 cells were either 
preincubated with PC-OVA, fractionated, and incubated with fixed M12.4.1 
as described in Fig. 3 (B), or they were fractionated without preincubation 
with antigen (and in the absence of protease inhibitors)  and incubated  at 
pH 5 with fixed M12.4.1 in the presence of 0.36 mg/ml OVA as described 
in Materials and Methods (C). (/1) Distribution  of markers from cells prein- 
cubated with PC-OVA and fractionated in the presence of protease inhibi- 
tors; similar distributions  were seen with untreated cells fractionated  in 
the absence ofprotease inhibitors. ---, plasma membrane;  nlysosomes; 
￿9 ￿9 -, transferrin  receptor;  m,  MHC class II. II:2 values for control in- 
cubations  in B are as follows: control (medium only), 0 U/ml; 4 mg/ml 
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Figure  9.  Effect  of  low  temperature  incubation  on  intracellular 
trafficking and antigen processing. Transfected A20 cells were incubated 
at 4~  with PE-GAH/~ (B) or PC-OVA (C),  washed,  and internalized 
for 30 min at either 18~  (m)  or 37~  (-"). Characteristic  markers, 
shown in A, were not altered by the incubation at 18~  m,  plasma 
membrane; (APDE I); m,  lysosomes (/~-hexosaminidase). The distribu- 
tion of PE fluorescence is shown in B, and antigenic  activity (as deter- 
mined in Fig. 3) is shown  in C. 
OVA, 0 U/ml; 4 mg/ml t-OVA, 17 U/ml. IL-2 values for control incuba- 
tions in C are as follows: control (medium only), 0 U/ml; 4 mg/ml OVA, 
0 U/ml; 4 mg/ml t-OVA,  21.7 U/ml. 
1723  Barnes and Mitchell The ability to detect functional in vivo processed antigen 
probably results  from  several  features of our experimental 
system. The A20 cell line transfected with a PC-specific human 
mlgM construct is an extremely efficient APC, and the cells 
can be routinely cultured to yield 2-4  ￿  10  s cells, each with 
1-2  ￿  10  s mlgM molecules per cell. The antigenic specificity 
allows antigen binding in the cold, followed by a synchronous 
wave of internalization upon warming. Thus, large amounts 
of processed antigen can be generated in a relatively narrow 
temporal window, permitting accurate intracellular localiza- 
tion. By comparison, analysis of the intracellular sites of pro- 
cessing for pinocytosed antigen gave equivocal results (not 
shown), in large part due to the long incubation times re- 
quired to load these cells by pinocytosis (Fig.  1). With in- 
creasing incubation times, a greater proportion of pinocy- 
tosed antigen (or fragments) may enter organelles other than 
where processing is occurring. Moreover, at early time points, 
up to 2 h, the amount of antigen internalized by pinocytosis 
was not sufficient to generate a detectable stimulatory signal 
from subcellular fractions. The use of the DO.11 T  cell hy- 
bridoma with specificity for processed OVA peptide in the 
context of I-A  a (12)  was also advantageous in that DO.11 
can respond to peptide-MHC  class II complexes on planar 
membranes without a requirement for accessory molecules 
(49).  Consequently,  small amounts  of processed antigen- 
MHC complexes could be detected by a very sensitive bio- 
logic assay. In addition, the pertinent antigenic fragment of 
OVA (OVA323-339)  is in a relatively accessible portion of the 
molecule near a major open o~-helical loop (50). Thus, degra- 
dation of PC-OVA by the transfected A20 cells may proceed 
rapidly and eff￿  because of specific binding and intra- 
cellular targeting via the surface mlg (29,  51,  52),  and be- 
cause of physical and biochemical characteristics of the mole- 
cule. Although the antigenic epitope from F(ab')z-RGG that 
is recognized by 2R.50 is not known, the results with PC- 
F(ab')2-R.GG  (Fig.  2  C)  suggest  that  the  technique  may 
prove useful in determining the intracellular processing site(s) 
for a variety of antigens. 
The data in this article demonstrate that antigens internal- 
ized in association with  mlg on B  cells can be efficiently 
processed to class II-associated antigenic peptide fragments 
in low density endosomal compartments without the con- 
tribution of lysosomal proteolysis. Processed antigen is de- 
tected at 15 min in a compartment denoted as low density 
endosome based on the early entrance of internalized ligand 
(PC-OVA or PE-GAHg); it is distinct from early endosomes 
(marked by TfR) based on its density in an  11%  gradient 
(Fig. 6 C). Moreover, the low density compartment where 
processed antigen-class II complexes are detected after 15 min 
of internalization is clearly distinct from lysosomes identified 
by/~-hexosaminidase activity and the predominant peak of 
LAMP-1 antigenic@. Similar prelysosomal degradation (and 
subsequent lysosomal accumulation) of antigen in B cells has 
been observed by others (34, 35). The results are also in agree- 
ment with immunogold-electron microscopy data demon- 
strating early (2-30 rain) colocalization of cathepsins, class 
II, and mlg within an acidic, rapidly accessed endocytic com- 
partment  (38). 
Although T cell stimulatory processed antigen is detected 
only within this low density endosomal compartment, en- 
zymatic activity capable of degrading OVA to relevant anti- 
genic fragments is present in both low density endosomal 
and lysosomal compartments (Fig. 8 C). The demonstration 
of processing activity in low density endosomes is in agree- 
ment with other work (34, 35, 53-55); in addition, cathepsin 
D, an aspartyl protease inhibitable by pepstatin A and present 
within low density endosomes (56), has been shown to de- 
grade OVA  to fragments that will complex with class  II 
molecules and stimulate DO.11  T  cells (42).  As expected, 
antigen-processing activity is also present within dense or- 
ganelles consistent with lysosomes (7, 9, 34, 35, 57). How- 
ever, in contrast to previous work with macrophages (8, 39, 
40) or B cell lymphoblastoid cell lines (5, 41), little, if any, 
class II could be detected by an ELISA in the same compart- 
ment (Figs. 4, 5, and 8). In fact, class II appears to be largely 
confined to plasma membrane and low density organelles in 
A20 cells  (4).  Therefore, even if antigen is proteolytically 
degraded in lysosomes in these cells, it may not have access 
to class II molecules and may not be protected from com- 
plete proteolysis (58). Incubation at 18~  blocks the transit 
of internalized antigen to lysosomes, but it does not affect 
internalization or the processing of PC-OVA to stimulatory 
peptide fragments (Fig. 9). This is further evidence that an- 
tigen processing can occur within low-density compartments, 
accessed within minutes of endocytosis. Moreover, the results 
with fixed class II + and class II- cells (Fig. 5 B) suggest that 
processed peptide rapidly and effciently associates with class 
II molecules in the low density endosomal compartment. 
Our results are somewhat dissimilar to those described by 
Qiu et al.  (41),  who used a slightly different technique to 
assay for processed peptide in subcellular fractions. By directly 
incubating Percoll subcellular fractions from antigen-pulsed 
APC with responding T cells, they found that the majority 
of processed antigen taken up by mlg in a CH27 B cell lym- 
phoma line was present in dense compartments colocalizing 
with lysosomes (41). However, their assay does not exclude 
the possibility that the subcellular fractions from antigen- 
pulsed cells were generating processed peptides de novo during 
the 24-h incubation with T cells (41). Alternatively, the differ- 
ences between the two sets of results may be related to the 
use of different antigens (cytochrome C  in the case of Qiu 
et al. and OVA and RGG in this study) with different pro- 
cessing requirements for the generation of antigenic peptide 
fragments.  Finally, the dense organeUe with processed an- 
tigen in the CH27 routine B cell lymphoma line (41) may 
be analogous to the relatively dense MIIC compartment de- 
scribed by Peters et al. (5) in a human B lymphoblastoid cell 
line and a similar higher density organelle (8  --  1.06) de- 
scribed by West et al. (6), also in human B lymphoblastoid 
cells. The low density endosomal organelle described in our 
work with transfected murine A20 B cell lymphoma cells 
(8 "~1.044)  is most likely the low density CIIV described 
by Amigorena et al. (4), also in A20 cells. It is possible that 
all of these organelles represent a similar specialized processing 
compartment in B cells, differing primarily in their physical 
characteristics between various cell lines. 
1724  Antigen Processing in Low Density Endosomes Germane to this point are the results of Harding and Geuze 
(8), who used a technique similar to Qiu et al. (41) to assay 
processed antigen-class II complexes in subcellular fractions 
from macrophages. They found that in macrophages where 
antigen was internalized by pinocytosis, processing and class 
II association occurred largely in a class II-enriched, high 
density tubulovesicular lysosomal compartment. Since the 
lysosomal compartment(s) is likely to be the end repository 
for the bulk of pinocytosed protein fragments in macrophages, 
the tubulovesicular  lysosome may be the specialized organelle 
in these cells analogous to the CIIV or MIIC in B cells. 
In summary, antigen bound to mlg can be rapidly and 
efficiently  processed to peptide-class II complexes within low 
density endosomes without the contribution of lysosomal 
degradation. Both proteolytic activity and the availability of 
class II molecules determine the intracellular site where func- 
tional processed  antigen is generated. 
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